Public Profile

Fresenius Medical Care

Fresenius Medical Care, a leading global provider of products and services for individuals with renal diseases, is headquartered in the United States. Founded in 1996, the company has established a strong presence in North America, Europe, and Asia, focusing on dialysis services and the manufacture of dialysis equipment. With a commitment to innovation, Fresenius Medical Care offers a comprehensive range of products, including dialysis machines and consumables, which are distinguished by their advanced technology and patient-centric design. The company is recognised for its significant market position, serving millions of patients worldwide and achieving notable milestones in improving patient outcomes. As a key player in the healthcare industry, Fresenius Medical Care continues to lead in the development of integrated care solutions, enhancing the quality of life for those affected by chronic kidney disease.

DitchCarbon Score

How does Fresenius Medical Care's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

64

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

23

Industry Benchmark

Fresenius Medical Care's score of 64 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.

98%

Let us know if this data was useful to you

Fresenius Medical Care's reported carbon emissions

In 2023, Fresenius Medical Care reported total carbon emissions of approximately 3,680,827,000 kg CO2e. This figure includes 387,049,000 kg CO2e from Scope 1 emissions, which primarily arise from direct operations, and 466,600,000 kg CO2e from Scope 2 emissions, related to purchased electricity and heat. Additionally, Scope 3 emissions accounted for about 3,958,000,000 kg CO2e, encompassing indirect emissions from the supply chain and product use. Fresenius Medical Care has committed to achieving net-zero emissions across all scopes by 2050, as part of its long-term climate strategy. This commitment aligns with the Science Based Targets initiative (SBTi), which the company joined in 2024. The company has set a baseline year of 2023 for its emissions reduction efforts, although specific percentage reduction targets have not been disclosed. Over the years, the company has seen fluctuations in its emissions, with Scope 1 emissions increasing from 218,700,000 kg CO2e in 2018 to 387,049,000 kg CO2e in 2023. Scope 2 emissions also varied, peaking at 557,200,000 kg CO2e in 2018 before decreasing to 466,600,000 kg CO2e in 2023. The company has disclosed emissions data for all three scopes, demonstrating transparency in its environmental impact reporting. Fresenius Medical Care's ongoing commitment to sustainability and climate action reflects its recognition of the healthcare sector's role in addressing climate change, aiming to reduce its carbon footprint while continuing to provide essential healthcare services.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2018201920202021202220232024
Scope 1
218,700,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
557,200,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
000,000,000
000,000,000
000,000,000
000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Fresenius Medical Care's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Fresenius Medical Care is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Fresenius Medical Care is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Glaxosmithkline

GB
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

GE HealthCare

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 days ago

Danaher Corporation

US
Chemicals nec
Updated 2 days ago

Haleon plc

GB
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Getinge

SE
Health and social work services (85)
Updated 2 days ago

Boston Scientific

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers